Operating Expenses Summary of TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited's latest annual operating expenses in 2023 was 258.77 Million TWD , down -16.57% from previous year.
TaiGen Biopharmaceuticals Holdings Limited's latest quarterly operating expenses in 2024 Q2 was 67.64 Million TWD , up 4.24% from previous quarter.
TaiGen Biopharmaceuticals Holdings Limited reported a annual operating expenses of 310.16 Million TWD in annual operating expenses 2022, down -18.88% from previous year.
TaiGen Biopharmaceuticals Holdings Limited reported a annual operating expenses of 382.34 Million TWD in annual operating expenses 2021, up 17.03% from previous year.
TaiGen Biopharmaceuticals Holdings Limited reported a quarterly operating expenses of 67.64 Million TWD for 2024 Q2, up 4.24% from previous quarter.
TaiGen Biopharmaceuticals Holdings Limited reported a quarterly operating expenses of 70.18 Million TWD for 2023 Q3, up 4.13% from previous quarter.

Annual Operating Expenses Chart of TaiGen Biopharmaceuticals Holdings Limited (2023 - 2010)

Historical Annual Operating Expenses of TaiGen Biopharmaceuticals Holdings Limited (2023 - 2010)

Year	Operating Expenses	Operating Expenses Growth
2023	258.77 Million TWD	-16.57%
2022	310.16 Million TWD	-18.88%
2021	382.34 Million TWD	17.03%
2020	326.7 Million TWD	12.72%
2019	289.84 Million TWD	1.9%
2018	284.45 Million TWD	-0.73%
2017	286.53 Million TWD	-22.21%
2016	368.34 Million TWD	-24.73%
2015	489.34 Million TWD	-1.27%
2014	495.62 Million TWD	-10.08%
2013	551.18 Million TWD	5.08%
2012	524.53 Million TWD	27.11%
2011	412.65 Million TWD	-9.2%
2010	454.44 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	58.81 Million TWD	-31.12%
2024 Q2	67.64 Million TWD	4.24%
2023 Q3	70.18 Million TWD	4.13%
2023 FY	258.77 Million TWD	-16.57%
2023 Q1	56.98 Million TWD	-36.24%
2023 Q2	67.39 Million TWD	18.28%
2023 Q4	85.38 Million TWD	21.66%
2022 Q3	39.77 Million TWD	-60.73%
2022 FY	310.16 Million TWD	-18.88%
2022 Q1	79.76 Million TWD	-33.14%
2022 Q2	101.26 Million TWD	26.95%
2022 Q4	89.36 Million TWD	124.71%
2021 Q4	119.3 Million TWD	65.43%
2021 FY	382.34 Million TWD	17.03%
2021 Q2	121.19 Million TWD	73.82%
2021 Q3	72.11 Million TWD	-40.5%
2021 Q1	69.72 Million TWD	-38.62%
2020 Q3	92.59 Million TWD	43.9%
2020 Q1	56.16 Million TWD	-35.31%
2020 Q4	113.6 Million TWD	22.69%
2020 FY	326.7 Million TWD	12.72%
2020 Q2	64.34 Million TWD	14.56%
2019 Q3	70.3 Million TWD	-0.81%
2019 Q1	61.83 Million TWD	-29.17%
2019 Q2	70.87 Million TWD	14.63%
2019 Q4	86.82 Million TWD	23.5%
2019 FY	289.84 Million TWD	1.9%
2018 Q1	62.88 Million TWD	-15.66%
2018 Q4	87.29 Million TWD	23.04%
2018 Q3	70.94 Million TWD	12.02%
2018 Q2	63.33 Million TWD	0.71%
2018 FY	284.45 Million TWD	-0.73%
2017 FY	286.53 Million TWD	-22.21%
2017 Q2	76.92 Million TWD	25.48%
2017 Q1	61.3 Million TWD	-45.25%
2017 Q3	73.75 Million TWD	-4.12%
2017 Q4	74.55 Million TWD	1.09%
2016 Q2	82.24 Million TWD	-11.52%
2016 Q3	81.16 Million TWD	-1.32%
2016 FY	368.34 Million TWD	-24.73%
2016 Q4	111.97 Million TWD	37.96%
2016 Q1	92.95 Million TWD	-33.86%
2015 Q2	124.36 Million TWD	27.12%
2015 Q4	140.53 Million TWD	11.01%
2015 Q3	126.6 Million TWD	1.8%
2015 Q1	97.83 Million TWD	-34.21%
2015 FY	489.34 Million TWD	-1.27%
2014 Q2	128.63 Million TWD	34.78%
2014 Q1	95.43 Million TWD	-48.62%
2014 Q4	148.69 Million TWD	21.03%
2014 FY	495.62 Million TWD	-10.08%
2014 Q3	122.86 Million TWD	-4.48%
2013 Q2	117.35 Million TWD	32.86%
2013 Q4	185.73 Million TWD	16.26%
2013 Q3	159.75 Million TWD	36.13%
2013 FY	551.18 Million TWD	5.08%
2013 Q1	88.33 Million TWD	-53.96%
2012 Q4	191.85 Million TWD	39.71%
2012 Q3	137.32 Million TWD	0.0%
2012 FY	524.53 Million TWD	27.11%
2011 FY	412.65 Million TWD	-9.2%
2010 FY	454.44 Million TWD	0.0%

Peer Operating Expenses Comparison of TaiGen Biopharmaceuticals Holdings Limited

Name	Operating Expenses	Operating Expenses Difference
SYN-TECH Chem. & Pharm. Co., Ltd.	127.67 Million TWD	-102.694%
Level Biotechnology Inc.	151.99 Million TWD	-70.257%
Sagittarius Life Science Corp	135.85 Million TWD	-90.485%
NeoCore Technology Co., Ltd.	75.85 Million TWD	-241.132%
TaiMed Biologics Inc.	225.23 Million TWD	-14.894%
GlycoNex Incorporation	995 Thousand TWD	-25907.94%
VBI	32.55 Million TWD	-694.898%
GeneReach Biotechnology Corp.	256.86 Million TWD	-0.744%
Taiwan Advance Bio-Pharmaceutical Inc.	194.18 Million TWD	-33.263%
Visgeneer Inc.	67.48 Million TWD	-283.479%
Mycenax Biotech Inc.	-375.19 Million TWD	168.973%
Sunmax Biotechnology Co., Ltd.	510.09 Million TWD	49.268%
G&E Herbal Biotechnology Co., Ltd.	63.9 Million TWD	-304.956%
Medigen Vaccine Biologics Corporation	1.44 Billion TWD	82.08%
TaiwanJ Pharmaceuticals Co., Ltd.	29.35 Million TWD	-781.64%
Enimmune corporation	220.1 Million TWD	-17.572%
TaiRx, Inc.	217.13 Million TWD	-19.179%
CHO Pharma, Inc.	268.99 Million TWD	3.799%
EirGenix Inc.	236.74 Million TWD	-9.309%
BioLASCO Taiwan Co., Ltd.	104.35 Million TWD	-147.989%
Sunny Pharmtech Inc.	357.62 Million TWD	27.639%
Lin BioScience, Inc.	1.09 Billion TWD	76.407%
BioGend Therapeutics Co., Ltd.	266.15 Million TWD	2.773%
Feng Chi Biotech Corp.	49.47 Million TWD	-423.092%
Bio Preventive Medicine Corp.	1.08 Million TWD	-23794.645%
Lukas Biomedical Inc.	177.45 Million TWD	-45.832%
RBC Bioscience Corporation	58.35 Million TWD	-343.449%
BiOptic Inc.	108.69 Million TWD	-138.085%
BRIM Biotechnology, Inc.	90 Thousand TWD	-287432.222%
Shine-On BioMedical Co.,Ltd.	69.35 Million TWD	-273.149%
Great Novel Therapeutics Biotech & Medicals	2.61 Million TWD	-9795.946%
Syngen Biotech Co.,Ltd.	643.91 Million TWD	59.812%
Anti-Microbial Savior BioteQ Co., Ltd	329 Thousand TWD	-78556.231%
SynCore Biotechnology Co.,Ltd	46.02 Million TWD	-462.282%
Genomics BioSci & Tech. Co.,Ltd.	119.91 Million TWD	-115.811%
Neith Corporation	66.87 Million TWD	-286.971%
Advagene Biopharma Co., Ltd.	93.33 Million TWD	-177.255%
NaviFUS Corp.	11.82 Million TWD	-2088.036%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	190.72 Million TWD	-35.679%
Sinew Pharma Inc.	186.25 Million TWD	-38.94%
Andros Pharmaceuticals Co.,Ltd	74.02 Million TWD	-249.593%
Greenyn Biotechnology Co., Ltd	220.39 Million TWD	-17.414%
Lumosa Therapeutics Co., Ltd.	41.48 Million TWD	-523.849%
AP Biosciences Inc	32.25 Million TWD	-702.341%
Medigen Biotechnology Corp.	1.85 Billion TWD	86.015%
3D Global Biotech Inc.	5.27 Million TWD	-4806.693%
Pharmosa Biopharm Inc.	317.32 Million TWD	18.45%
Intech Biopharm Corporation	-163.99 Million TWD	257.797%
Oneness Biotech Co., Ltd.	1.12 Billion TWD	77.083%
Eusol Biotech Co.,Ltd.	41.48 Million TWD	-523.834%
TWi Biotechnology, Inc.	169.55 Million TWD	-52.622%
Ever Supreme Bio Technology Co., Ltd	147.02 Million TWD	-76.014%
TCI GENE Inc.	174.61 Million TWD	-48.198%
MegaPro Biomedical Co., Ltd	18 Thousand TWD	-1437561.111%
Senhwa Biosciences, Inc.	300.93 Million TWD	14.009%
Taiwan Bio Therapeutics Co., Ltd	290.95 Million TWD	11.059%
NatureWise Biotech & Medicals Corporation	83.94 Million TWD	-208.272%
PharmaEngine, Inc.	441.78 Million TWD	41.425%
Savior Lifetec Corporation	223.36 Million TWD	-15.853%
OBI Pharma, Inc.	2.01 Billion TWD	87.166%
Meribank Biotech Co., Ltd	138.87 Million TWD	-86.346%
Acepodia, Inc.	452.56 Million TWD	42.82%
Caliway Biopharmaceuticals Co., Ltd.	540.93 Million TWD	52.161%

Global Stocks Search

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)

Operating Expenses Summary of TaiGen Biopharmaceuticals Holdings Limited

Annual Operating Expenses Chart of TaiGen Biopharmaceuticals Holdings Limited (2023 - 2010)

Historical Annual Operating Expenses of TaiGen Biopharmaceuticals Holdings Limited (2023 - 2010)

Peer Operating Expenses Comparison of TaiGen Biopharmaceuticals Holdings Limited